-
1
-
-
0024546736
-
Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
-
Fornander T, Cedermark B, Mattson A, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1989, i, 117-120.
-
(1989)
Lancet
, vol.1
, pp. 117-120
-
-
Fornander, T.1
Cedermark, B.2
Mattson, A.3
-
2
-
-
0025886813
-
Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer
-
Andersson M, Storm HH, Mouridson HT. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 1991, 83, 1013-1017.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 1013-1017
-
-
Andersson, M.1
Storm, H.H.2
Mouridson, H.T.3
-
3
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
Van Leeuwen FE, Benraadt J, Coebergh JWW, et al. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994, 343, 448-452.
-
(1994)
Lancet
, vol.343
, pp. 448-452
-
-
Van Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.W.3
-
4
-
-
0028129023
-
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial
-
Powles TJ, Jones AL, Ashley SE, et al. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 1994, 31, 73-82.
-
(1994)
Breast Cancer Res Treat
, vol.31
, pp. 73-82
-
-
Powles, T.J.1
Jones, A.L.2
Ashley, S.E.3
-
5
-
-
0028266275
-
Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth
-
Cohen I, Rosen DJD, Altaras MM, Beyth Y, Shapira J, Yigael D. Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth. Br J Cancer 1994, 63, 620-621.
-
(1994)
Br J Cancer
, vol.63
, pp. 620-621
-
-
Cohen, I.1
Rosen, D.J.D.2
Altaras, M.M.3
Beyth, Y.4
Shapira, J.5
Yigael, D.6
-
6
-
-
0026591069
-
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st Grocta (Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group) Trial
-
Boccardo F, Rubagotti A, Amoroso D, et al. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st Grocta (Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group) Trial. Eur J Cancer 1992, 28A, 673-680.
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 673-680
-
-
Boccardo, F.1
Rubagotti, A.2
Amoroso, D.3
-
7
-
-
0026553956
-
Oral contraceptive type and functional ovarian cysts
-
Lanes SF, Birman B, Walker AM, Singer S. Oral contraceptive type and functional ovarian cysts. Am J Obstet Gynecol 1992, 166, 956-961.
-
(1992)
Am J Obstet Gynecol
, vol.166
, pp. 956-961
-
-
Lanes, S.F.1
Birman, B.2
Walker, A.M.3
Singer, S.4
-
8
-
-
0345540209
-
Ovarian cysts in women receiving tamoxifen in a randomized adjuvant breast cancer study +/-high-dose chemotherapy
-
De Vries EGE, Mounts MJE, ten Hoor KA et al. Ovarian cysts in women receiving tamoxifen in a randomized adjuvant breast cancer study +/-high-dose chemotherapy. Proc Am Soc Clin Oncol 1997, 16, 580.
-
(1997)
Proc Am Soc Clin Oncol
, vol.16
, pp. 580
-
-
De Vries, E.G.E.1
Mounts, M.J.E.2
Ten Hoor, K.A.3
|